Nonetheless, this study demonstrates that Ly9 may not only prove to be a valuable target for the treatment of autoimmunity, but may also help build a more rational road map toward understanding the molecular causes of SLE syndrome. This evidence concerns the gene LY9 and Autoimmunity.